DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paclitaxel (Paclitaxel) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (176)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Paclitaxel where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 176   Next >>

Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-23

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer
    Start date: 2012-06-15

Lapatinib
    Dosage: 750mg per day
    Indication: Breast Cancer
    Start date: 2012-06-15

Liposome Encapsulated Doxorubicin Citrate Complex
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-15

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer
    Start date: 2012-06-15

Trastuzumab
    Dosage: 6mgk every 3 weeks
    Indication: Breast Cancer
    Start date: 2012-06-15

Other drugs received by patient: Loperamide; Neupogen



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-08-22

Patient: 54 year old female, weighing 47.0 kg (103.4 pounds)

Reactions: Abdominal Pain, Vomiting, Nausea, Anaemia, Hypokalaemia, Small Intestinal Obstruction, Hypomagnesaemia, Platelet Count Decreased, Hypoalbuminaemia, Neutrophil Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: last dose prior to sae was taken on 29/jun/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-06-29

Carboplatin
    Dosage: auc= 6 over 30 minutes on day 1. last dose prior to sae was taken on 29/may/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-05-29

Paclitaxel
    Dosage: last dose prior to sae was taken on 06/jul/2012. day 15 held due to sbo.
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-07-06

Veliparib
    Dosage: last dose prior to sae was taken on 03/jul/2012
    Administration route: Oral
    Indication: Ovarian Epithelial Cancer



Possible Paclitaxel side effects in 56 year old female

Reported by a physician from United States on 2012-08-22

Patient: 56 year old female, weighing 91.2 kg (200.6 pounds)

Reactions: Anaemia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2010-11-10
    End date: 2011-01-12

Doxorubicin Hydrochloride
    Dosage: 60mgm2 cyclic
    Indication: Breast Cancer
    Start date: 2010-11-10
    End date: 2011-01-12

Paclitaxel
    Dosage: 65mgm2 cyclic
    Indication: Breast Cancer
    Start date: 2011-02-03
    End date: 2011-04-13

Pazopanib
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-02-03
    End date: 2011-04-10

Other drugs received by patient: Armodafinil



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-08-21

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-08-20

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Fatigue, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Carboplatin
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-18
    End date: 2012-08-09



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-27

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Anaemia, Tachycardia, Pyrexia, Multi-Organ Failure, Urosepsis, Acute Respiratory Distress Syndrome, Oedema, Hypoxia, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Metoprolol Tartrate; Xanax; Vicodin; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-24

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Anaemia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose: auc 2min/ml, last dose prior to sae on: 11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-02-02
    End date: 2012-06-19

Doxorubicin Hydrochloride
    Dosage: last dose prior to sae on: 11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-02-02
    End date: 2012-06-19

Herceptin
    Dosage: date of last dose prior to sae: 18/may/2012
    Indication: Breast Cancer
    Start date: 2012-02-02
    End date: 2012-06-19

Lapatinib
    Dosage: last dose prior to sae:18 jun 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-02-02
    End date: 2012-06-19

Paclitaxel
    Dosage: last dose prior to sae on: 11/jun/2012
    Indication: Breast Cancer
    Start date: 2012-02-02
    End date: 2012-06-19



Possible Paclitaxel side effects in 60 year old female

Reported by a physician from United States on 2012-07-24

Patient: 60 year old female, weighing 111.2 kg (244.6 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Anaemia, Hyperglycaemia, International Normalised Ratio Increased, Hyponatraemia, Device Related Infection, Seroma, Hypophosphataemia, Skin Ulcer, Proteinuria, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutes on day 1 (starting with cycle 2 for those patients entering post surgery) x 6 cyc
    Indication: Endometrial Cancer
    Start date: 2011-01-13

Avastin
    Dosage: maintainence therapy (cycles 7+), over 30-90 mins on day 1

Carboplatin
    Dosage: auc = 6 iv over 30 minutes on day 1 x 6 cycles, last dose prior to sae: 27/feb/2012
    Indication: Endometrial Cancer
    Start date: 2011-01-13

Paclitaxel
    Dosage: over 3 hrs on day 1 x 6 cycles, last dose prior to sae: 27/feb/2012
    Indication: Endometrial Cancer
    Start date: 2011-01-13



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-23

Patient: female, weighing 93.0 kg (204.5 pounds)

Reactions: Tooth Loss, Tricuspid Valve Incompetence, Hot Flush, Mood Altered, Iron Deficiency Anaemia, Retinal Pigment Epitheliopathy, Back Pain, Osteopenia, Cervical Dysplasia, Joint Injury, Diverticulum, Metastases To Spine, Compression Fracture, Pancreatitis, Calculus Ureteric, Upper-Airway Cough Syndrome, Adnexa Uteri Cyst, Vitreous Floaters, Hydroureter, Depression, Injury, Decreased Appetite, Vomiting, Cataract, Retinal Melanoma, Lung Neoplasm, Musculoskeletal Pain, Thyroid Cyst, Pulmonary Valve Incompetence, Arthralgia, Oral Pain, Mitral Valve Incompetence, Asthenia, DRY Eye, Abdominal Hernia, Night Sweats, Weight Decreased, Femur Fracture, Metastases To Liver, Nocturia, Headache, Pericardial Effusion, Tendon Injury, Neoplasm Skin, Dyspepsia, Sexually Transmitted Disease, Sinus Congestion, Mastoid Disorder, Intervertebral Disc Protrusion, Hydronephrosis, Hiatus Hernia, Cardiac Murmur, Peptic Ulcer, Anaemia, General Physical Health Deterioration, Renal Cyst, Hypoaesthesia, Atelectasis, Pain, Bone Pain, Conjunctivitis, Nephrolithiasis, Fatigue, Neuropathy Peripheral, Biliary Dyskinesia, Photophobia, Pleural Effusion, Intervertebral Disc Degeneration, Sinusitis, RIB Fracture, Spondylolisthesis, Nausea, Myopia, Anxiety, Osteonecrosis of JAW, Diarrhoea, Oral Disorder, Osteosarcoma Metastatic, Bronchitis, Hypertension, Deep Vein Thrombosis

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, unk
    End date: 2001-02-21

Paclitaxel

Zometa
    Dosage: 4 mg, unk
    Indication: Metastases To Bone
    Start date: 2002-03-04
    End date: 2004-09-01

Other drugs received by patient: Lipitor; Cefuroxime Axetil; Vitamin D; Hydrocodone Bitartrate and Acetaminophen; Motrin; Cytoxan; Folate Sodium; Oxycodone HCL; Amoxicillin; Trazodone Hydrochloride; Depo-Medrol; Arimidex; Radiation Therapy; Lupron; Paxil; Sertraline Hydrochloride; Zoloft; Robaxin; Magnesium Sulfate; Alpha Lipoic Acid; Aromasin; Avastin; Femara; Prochlorperazine; Aspirin; Multivitamin ^lappe^; Adriamycin PFS; Anzemet; Fish OIL; Turmeric; Simvastatin; Calcium; Zoladex; Taxotere; Hydrogen Peroxide Mouth Rinse; Methocarbamol; Prilosec; Penicillin VK; Dexamethasone; Clindamycin; Fexofenadine; Taxol; Ethyol; Magace; Pepcid; Lortab; Oophorectomy



Possible Paclitaxel side effects in 65 year old female

Reported by a physician from Germany on 2012-07-23

Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)

Reactions: Weight Decreased, Fistula, Nausea, Anaemia, General Physical Health Deterioration, Fatigue, Sepsis, Decreased Appetite, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-03-21
    End date: 2012-04-18

Avastin
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Carboplatin
    Dosage: auc 5,
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Carboplatin
    Dosage: auc 5, last dose:15/may/2012
    End date: 2012-06-10

Paclitaxel
    Dosage: last dose:15/may/2012
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Paclitaxel
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Other drugs received by patient: Novalgin; Pantoprazole; Zolpidem



Possible Paclitaxel side effects in 62 year old male

Reported by a physician from Japan on 2012-07-19

Patient: 62 year old male

Reactions: Blood Pressure Increased, Anaemia, Posterior Reversible Encephalopathy Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 6 min-mg/ml on day 1 every 3 weeks
    Indication: Adenosquamous Cell Lung Cancer Stage III

Paclitaxel
    Dosage: 200mg/m2 on day 1 every 3 weeks
    Indication: Adenosquamous Cell Lung Cancer Stage III

Other drugs received by patient: Paraplatin; Paclitaxel



Possible Paclitaxel side effects in 62 year old male

Reported by a individual with unspecified qualification from Japan on 2012-07-18

Patient: 62 year old male

Reactions: Blood Pressure Increased, Head Discomfort, Oral Disorder, Anaemia, Posterior Reversible Encephalopathy Syndrome

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 6 min mg/ml intravenous (not otherwise specified)
    Indication: non-Small Cell Lung Cancer

Paclitaxel
    Dosage: 200 mg/m2, intravenous (not specified)
    Indication: non-Small Cell Lung Cancer

Other drugs received by patient: Dexamethasone Sodium Phosphate



Possible Paclitaxel side effects in 63 year old female

Reported by a physician from United States on 2012-07-18

Patient: 63 year old female, weighing 122.7 kg (270.0 pounds)

Reactions: Vomiting, Nausea, Pain, Anaemia, Hypokalaemia, Haemoglobin Decreased, Diarrhoea, Skin Ulcer, Hypomagnesaemia, Dehydration, Hypoalbuminaemia, Hypocalcaemia, Vaginal Infection, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 minutes on day 1,starting with cycle 2 x6 cycles, no prior radiotherapy
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Avastin
    Dosage: prior radiotherapy, iv over 30-90 minutes on day 1 (

Carboplatin
    Dosage: auc = 5 iv over 30 minutes on day 1 x 6 cycles

Carboplatin
    Dosage: no prior radiotherapy, auc = 6 iv over 30 minutes on day 1 x 6 cycles
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Paclitaxel
    Dosage: prior radiotherapy,over 3 hrs on day 1 x 6 cycles

Paclitaxel
    Dosage: no prior radiotherapy, iv over 3 hrs on day 1 x 6 cycles
    Indication: Endometrial Cancer
    Start date: 2011-05-02

Other drugs received by patient: Arixtra; Percocet; Lyrica



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Dyspnoea, Pneumonia, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Hypoxia, Urosepsis, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: unk

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Duoneb; Lovenox; Vicodin; Xanax; Metoprolol Tartrate; Benadryl; Protonix



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-17

Patient: female, weighing 44.2 kg (97.2 pounds)

Reactions: Device Leakage, Urinary Tract Infection, Anaemia, Urinary Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 190 mg
    End date: 2012-07-10

Topotecan
    Dosage: 2.4 mg
    End date: 2012-07-12



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-17

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Anaemia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Lapatinib
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Trastuzumab
    Dosage: 6mg every 3 weeks
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19



Possible Paclitaxel side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Pneumonia, Dyspnoea, Tachycardia, Anaemia, Pyrexia, Multi-Organ Failure, Urosepsis, Hypoxia, Oedema, Escherichia Infection, Asthenia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-18

Afinitor
    Dosage: unk

Comparator Trastuzumab
    Dosage: 137 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-10

Paclitaxel
    Dosage: 142 mg
    Indication: Breast Cancer Metastatic
    Start date: 2010-12-23
    End date: 2011-03-03

Vancomycin
    Dosage: 1 g, q12h
    Start date: 2011-03-16

Other drugs received by patient: Xanax; Metoprolol Tartrate; Vicodin; Benadryl; Protonix; Duoneb; Lovenox



Possible Paclitaxel side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-10

Patient: female, weighing 85.0 kg (187.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 9.3 g

Neulasta
    Dosage: 6 mg

Paclitaxel
    Dosage: 262 mg



Possible Paclitaxel side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06

Patient: male

Reactions: Blood Alkaline Phosphatase Increased, Blood Pressure Increased, Anaemia, Posterior Reversible Encephalopathy Syndrome, Eyelid Ptosis, Platelet Count Decreased, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 6 min?mg/ml
    Indication: Adenosquamous Cell Lung Cancer Stage III

Paclitaxel
    Dosage: 200 mg/m2, unk
    Indication: Adenosquamous Cell Lung Cancer Stage III

Other drugs received by patient: Dexamethasone



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-05

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Anaemia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose: 2 auc, last dose: 11 jun 2012
    Indication: Breast Cancer
    Start date: 2012-02-02

Doxorubicin HCL
    Dosage: last dose: 11 jun 2012
    Indication: Breast Cancer
    Start date: 2012-02-02

Herceptin
    Dosage: last dose: 18-may-2012
    Indication: Breast Cancer
    Start date: 2012-02-02

Lapatinib
    Dosage: frequency: daily, last dose prior to sae:18 jun 2012
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-02-02

Paclitaxel
    Dosage: last dose: 11 jun 2012
    Indication: Breast Cancer
    Start date: 2012-02-02



Possible Paclitaxel side effects in 66 year old female

Reported by a physician from United States on 2012-07-02

Patient: 66 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Anaemia, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: latest received date:08/mar/2012
    Indication: Ovarian Epithelial Cancer
    Start date: 2012-02-16

Carboplatin
    Dosage: latest received date: 22/may/2012
    Indication: Ovarian Epithelial Cancer

Paclitaxel
    Dosage: latest received date: 22/may/2012
    Indication: Ovarian Epithelial Cancer



Possible Paclitaxel side effects in male

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-07-02

Patient: male

Reactions: Tumour Necrosis, Pulmonary Haemorrhage, Immune Reconstitution Syndrome, Cytomegalovirus Chorioretinitis, Anaemia, Kaposi's Sarcoma, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Combivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-02-02

Darunavir Hydrate
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2009-02-01
    End date: 2012-03-08

Dolutegravir Tablet
    Dosage: daily
    Indication: HIV Infection
    Start date: 2012-02-02

Etravirine
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-01
    End date: 2012-03-08

Ganciclovir
    Dosage: daily
    Indication: Cytomegalovirus Chorioretinitis
    Start date: 2012-02-15
    End date: 2012-03-05

Ganciclovir
    Start date: 2012-03-06
    End date: 2012-03-06

Maraviroc
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-01-01
    End date: 2012-03-08

Norvir
    Dosage: daily
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2000-03-01
    End date: 2012-03-08

Paclitaxel
    Dosage: daily
    Indication: Kaposi's Sarcoma
    Start date: 2010-09-01



Possible Paclitaxel side effects in 60 year old female

Reported by a individual with unspecified qualification from United States on 2012-07-02

Patient: 60 year old female, weighing 111.2 kg (244.6 pounds)

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Anaemia, International Normalised Ratio Increased, Hyperglycaemia, Hyponatraemia, Device Related Infection, Seroma, Hypophosphataemia, Skin Ulcer, Proteinuria, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: maintainence therapy (cycles 7+), over 30-90 mins on day 1

Avastin
    Dosage: over 30-90 minutes on day 1 (starting with cycle 2 for those patients entering post surgery) x 6 cyc
    Indication: Endometrial Cancer
    Start date: 2011-01-13

Carboplatin
    Dosage: auc = 6 iv over 30 minutes on day 1 x 6 cycles, last dose prior to sae: 27/feb/2012
    Indication: Endometrial Cancer
    Start date: 2011-01-13

Paclitaxel
    Dosage: over 3 hrs on day 1 x 6 cycles, last dose prior to sae: 27/feb/2012
    Indication: Endometrial Cancer
    Start date: 2011-01-13



Possible Paclitaxel side effects in female

Reported by a physician from Japan on 2012-07-02

Patient: female, weighing 54.0 kg (118.8 pounds)

Reactions: Hyperglycaemia, Anaemia, Liver Disorder, Cerebral Ischaemia, Ascites, Pneumocystis Jiroveci Pneumonia, Renal Impairment, C-Reactive Protein Increased, Blood Potassium Decreased, Pleural Effusion, Epistaxis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-22
    End date: 2010-12-07

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-22
    End date: 2010-12-07

Blinded Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2009-12-22
    End date: 2010-12-07

Comparator Trastuzumab
    Dosage: 215 mg, unk
    Indication: Breast Cancer Metastatic
    End date: 2010-12-07

Furosemide

Paclitaxel
    Dosage: unk
    Start date: 2010-03-29
    End date: 2010-11-02

Paclitaxel
    Dosage: 112 mg, unk
    Indication: Breast Cancer Metastatic
    End date: 2010-03-15

Sulfamethoxazole and Trimethoprim

Other drugs received by patient: Cefazolin Sodium; Prednisolone Sodium Succinate INJ; Loxoprofen Sodium; Amitriptyline HCL; Azunol; Imidapril Hydrochloride; Vancomycin; Hirudoid; Flavoxate Hydrochloride; Laxoberon



Possible Paclitaxel side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: female, weighing 120.6 kg (265.3 pounds)

Reactions: Vomiting, Hypersensitivity, Neutrophil Count, Nausea, Anaemia, Constipation, Hypokalaemia, Haemoglobin Decreased, Fatigue, Platelet Count Decreased, Asthenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-03-21

Carboplatin
    Dosage: dose: 5 auc
    Start date: 2012-03-21
    End date: 2012-04-11

Carboplatin
    Dosage: dose: 6 auc
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-04-11

Paclitaxel
    Indication: Ovarian Cancer
    Start date: 2012-02-29
    End date: 2012-04-11

Other drugs received by patient: Palonosetron; Ranitidine; Colace; Dexamethasone; Lovenox; Benadryl; Reglan



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-07-02

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Anaemia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Lapatinib
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19

Trastuzumab
    Dosage: 6mg every 3 weeks
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02
    End date: 2012-06-19



Possible Paclitaxel side effects in 48 year old female

Reported by a physician from United States on 2012-06-28

Patient: 48 year old female, weighing 78.0 kg (171.6 pounds)

Reactions: Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Paclitaxel
    Dosage: 80 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2010-02-09

Pegfilgrastim
    Dosage: 5 mug/kg, unk
    Indication: Breast Cancer
    Start date: 2010-02-09



Possible Paclitaxel side effects in 65 year old female

Reported by a physician from Germany on 2012-06-28

Patient: 65 year old female, weighing 46.4 kg (102.1 pounds)

Reactions: Weight Decreased, Fistula, Fatigue, Nausea, Sepsis, Anaemia, General Physical Health Deterioration, Decreased Appetite, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Ovarian Cancer
    Start date: 2012-03-21
    End date: 2012-04-18

Avastin
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Carboplatin
    Dosage: auc 5,
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Carboplatin
    Dosage: auc 5, last dose:15/may/2012
    End date: 2012-06-10

Paclitaxel
    Dosage: last dose:15/may/2012
    Indication: Ovarian Cancer
    Start date: 2012-02-27
    End date: 2012-04-18

Paclitaxel
    Dosage: last dose:15/may/2012
    End date: 2012-06-10

Other drugs received by patient: Pantoprazole; Zolpidem; Novalgin



Possible Paclitaxel side effects in 54 year old female

Reported by a physician from United States on 2012-06-26

Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Pancytopenia, Febrile Neutropenia, Device Related Infection, Neutrophil Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Carboplatin
    Dosage: 6 df, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Cyclophosphamide
    Dosage: 600 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Doxorubicin HCL
    Dosage: 60 mg/m2, unk
    Indication: Breast Cancer
    Start date: 2011-11-10

Paclitaxel
    Dosage: 80 mg/m2, per chemo regim
    Indication: Breast Cancer
    Start date: 2011-08-11

Pegfilgrastim
    Dosage: 480 mug, unk
    Indication: Chemotherapy
    Start date: 2011-12-22

Other drugs received by patient: Aloxi; Compazine; Decadron; Emend; Zofran; Tylenol (Caplet); Levaquin



Possible Paclitaxel side effects in female

Reported by a physician from Germany on 2012-06-26

Patient: female, weighing 56.0 kg (123.2 pounds)

Reactions: Anaemia, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02

Doxorubicin HCL
    Dosage: 20mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02

Lapatinib
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02

Paclitaxel
    Dosage: 80mgm2 weekly
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02

Trastuzumab
    Dosage: 6mg every 3 weeks
    Indication: Breast Cancer Metastatic
    Start date: 2012-02-02



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017